BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26143022)

  • 1. Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression.
    Leuchter AF; Cook IA; Feifel D; Goethe JW; Husain M; Carpenter LL; Thase ME; Krystal AD; Philip NS; Bhati MT; Burke WJ; Howland RH; Sheline YI; Aaronson ST; Iosifescu DV; O'Reardon JP; Gilmer WS; Jain R; Burgoyne KS; Phillips B; Manberg PJ; Massaro J; Hunter AM; Lisanby SH; George MS
    Brain Stimul; 2015; 8(4):787-94. PubMed ID: 26143022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of response to synchronized transcranial magnetic stimulation for major depressive disorder.
    Philip NS; Leuchter AF; Cook IA; Massaro J; Goethe JW; Carpenter LL
    Depress Anxiety; 2019 Mar; 36(3):278-285. PubMed ID: 30480860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of the use of EEG-based synchronized Transcranial Magnetic Stimulation (sTMS) for treatment of Major Depression.
    Jin Y; Phillips B
    BMC Psychiatry; 2014 Jan; 14():13. PubMed ID: 24438321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EEG synchronized left prefrontal transcranial magnetic stimulation (TMS) for treatment resistant depression is feasible and produces an entrainment dependent clinical response: A randomized controlled double blind clinical trial.
    George MS; Huffman S; Doose J; Sun X; Dancy M; Faller J; Li X; Yuan H; Goldman RI; Sajda P; Brown TR
    Brain Stimul; 2023; 16(6):1753-1763. PubMed ID: 38043646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.
    O'Reardon JP; Solvason HB; Janicak PG; Sampson S; Isenberg KE; Nahas Z; McDonald WM; Avery D; Fitzgerald PB; Loo C; Demitrack MA; George MS; Sackeim HA
    Biol Psychiatry; 2007 Dec; 62(11):1208-16. PubMed ID: 17573044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.
    Lipton RB; Dodick DW; Silberstein SD; Saper JR; Aurora SK; Pearlman SH; Fischell RE; Ruppel PL; Goadsby PJ
    Lancet Neurol; 2010 Apr; 9(4):373-80. PubMed ID: 20206581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain Activity and Clinical Outcomes in Adults With Depression Treated With Synchronized Transcranial Magnetic Stimulation: An Exploratory Study.
    Cook IA; Wilson AC; Corlier J; Leuchter AF
    Neuromodulation; 2019 Dec; 22(8):894-897. PubMed ID: 30637862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary assessment of the therapeutic efficacy of continuous theta-burst magnetic stimulation (cTBS) in major depression: a double-blind sham-controlled study.
    Chistyakov AV; Kreinin B; Marmor S; Kaplan B; Khatib A; Darawsheh N; Koren D; Zaaroor M; Klein E
    J Affect Disord; 2015 Jan; 170():225-9. PubMed ID: 25261629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain oscillation-synchronized stimulation of the left dorsolateral prefrontal cortex in depression using real-time EEG-triggered TMS.
    Zrenner B; Zrenner C; Gordon PC; Belardinelli P; McDermott EJ; Soekadar SR; Fallgatter AJ; Ziemann U; Müller-Dahlhaus F
    Brain Stimul; 2020; 13(1):197-205. PubMed ID: 31631058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronised transcranial magnetic stimulation for substance use-disordered Veterans: protocol for the pilot sham-controlled acceptability trial.
    Jampel J; Quinn MJ; Catalano JL; Benca-Bachman CB; Brick L; Philip NS; Swift RM; McGeary JE
    BMJ Open; 2023 Jan; 13(1):e066175. PubMed ID: 36717148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Deep Transcranial Magnetic Stimulation in Office Workers with Treatment-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial.
    Matsuda Y; Kito S; Igarashi Y; Shigeta M
    Neuropsychobiology; 2020; 79(3):208-213. PubMed ID: 31955155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcranial magnetic stimulation (TMS) in the treatment of attention-deficit/hyperactivity disorder in adolescents and young adults: a pilot study.
    Weaver L; Rostain AL; Mace W; Akhtar U; Moss E; O'Reardon JP
    J ECT; 2012 Jun; 28(2):98-103. PubMed ID: 22551775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of transcranial magnetic stimulation in pregnant women with major depressive disorder.
    Kim DR; Wang E; McGeehan B; Snell J; Ewing G; Iannelli C; O'Reardon JP; Sammel MD; Epperson CN
    Brain Stimul; 2019; 12(1):96-102. PubMed ID: 30249416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
    Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
    Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A pilot study of transcranial alternating current stimulation in the treatment of drug-naive adult patients with major depressive disorder].
    Wang HX; Wang K; Sun ZC; Peng M; Xue Q; Li N; Min BQ; Dong K; Zhang Q; Zhan SQ; Fan CQ; Zhou AH; Jia Y; Du JL; Zhou QL; Xu ZX; Song HQ; Wang YP
    Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(3):197-201. PubMed ID: 32008286
    [No Abstract]   [Full Text] [Related]  

  • 17. Electric field characteristics of low-field synchronized transcranial magnetic stimulation (sTMS).
    Zhi-De Deng ; Lisanby SH
    Annu Int Conf IEEE Eng Med Biol Soc; 2017 Jul; 2017():1445-1448. PubMed ID: 29060150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial.
    Fitzgerald PB; Brown TL; Marston NA; Daskalakis ZJ; De Castella A; Kulkarni J
    Arch Gen Psychiatry; 2003 Oct; 60(10):1002-8. PubMed ID: 14557145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between individual alpha peak frequency and clinical outcome with repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD).
    Corlier J; Carpenter LL; Wilson AC; Tirrell E; Gobin AP; Kavanaugh B; Leuchter AF
    Brain Stimul; 2019; 12(6):1572-1578. PubMed ID: 31378603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study.
    Harel EV; Rabany L; Deutsch L; Bloch Y; Zangen A; Levkovitz Y
    World J Biol Psychiatry; 2014 May; 15(4):298-306. PubMed ID: 22313023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.